UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 15


CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.



 

Commission File Number

333-137920

 

BioCube, Inc.

(Exact name of registrant as specified in its charter)

 

7320 North Dreamy Draw Drive, Suite 120, Phoenix, AZ 85020

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

     Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)

   X .

Rule 12g-4(a)(2)

        .

Rule 12h-3(b)(1)(i)  

        .

Rule 12h-3(b)(1)(ii)

        .

Rule 15d-6

        .

Rule 15d-22(b)

        .


    Approximate number of holders of record as of the certification or notice date:

93


     Pursuant to the requirements of the Securities Exchange Act of 1934 BioCube, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.


Date:

August 11, 2016

 

By:

/s/ Paul Lisak

 

 

 

 

Name  Paul Lisak

 

 

 

 

Its:      Chief Executive Officer





BioCube (CE) (USOTC:BICB)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 BioCube (CE) 차트를 더 보려면 여기를 클릭.
BioCube (CE) (USOTC:BICB)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 BioCube (CE) 차트를 더 보려면 여기를 클릭.